Bayer set a strategic alliance with J. Hopkins in retinal diseases
Bayer HealthCare and the Johns Hopkins University in Baltimore have entered into a five-year collaboration…
Bayer HealthCare and the Johns Hopkins University in Baltimore have entered into a five-year collaboration…
Novartis just paid the bill to Humabs to use its out-licensed drug candidate in a Phase…
The partnership between GlaxoSmithKline and Avalon Ventures launched three early-stage life science companies. Adrenergics, CadheRx…
Genmab and its partner Jonhson&Jonhson, through its subsidiary Janssen Biotech, are trying to speed up…
If a father works out every night and day at the gym, will he have…
MRC Technology and Peptinnovate teamed up to target bone diseases using peptides derived from the…
Immuno-oncology is a busy market to take on by yourself due to the existing fierce competition. Targovax…
Cassiopea, Cosmo Pharmaceutical’s spin-out, will be listed on the Swiss Stock Exchange. Cosmo Pharmaceutical plans…
Pieris Pharmaceutical is planning to raise €31M in an surprisingly low US IPO. The company…
Hundreds of millions of people all over the word suffer from type 2 Diabetes and…
PEP-Therapy and CleveXel Pharma will co-develop targeted therapy in oncology. The product is based on…
The world of Algae and Microalgae will be transformed thanks to the work of scientists of…